Search results

Nuclear medicine production at ANSTO 08/06/2018

Media Statement on nuclear medicine production

Reactor pool 200 x 145
Supply of nuclear medicine lutetium-177 for advanced prostate cancer highlighted in the news 09/05/2018

The supply of lutetium-177 from the OPAL multi-purpose reactor for an advanced stage prostate cancer clinical trial has garnered considerable media interest today.

Relay For Life 2018 logo 200 x 145
ANSTO fights cancer with a commitment to health research 03/05/2018

ANSTO is proud to be contributing to clinical trials by providing radioactive substances as imaging agents or as therapies. This weekend staff join the Cronulla Relay For Life event.

WFNMB 200 x 145
World Congress marked watershed moment for nuclear medicine and ANSTO 30/04/2018

ANSTO was closely associated with the 12th Congress of World Federation of Nuclear Medicine and Biology because of its diverse contribution as a member of the nuclear medicine community

Ben Fraser_ WFNMB
Deuteration impacting the world of nuclear medicine 23/04/2018

Dr Ben Fraser attended the 12th Congress of the World Federation of Nuclear Medicine and Biology (WFNMB) that was held in Melbourne (20-24 April), to present a poster entitled “[18F]D4-PBR111 - An Improved 2nd Generation Deuterated Radiotracer for Imaging Inflammation


Radiochemistry_WFNMB 200 x145
Congress marks watershed moment for nuclear medicine and ANSTO 20/04/2018

ANSTO is a partner organisation of the 12th Congress of the World Federation of Nuclear Medicine and Biology (WFNMB) being held in Melbourne.



Nuclear medicine supplies guaranteed during South Sydney fire crisis 17/04/2018

ANSTO to reopen to staff tomorrow 18th, April. School holiday workshops, external tours cancelled until Monday.

Australia’s OPAL multi-purpose reactor prepares for new milestone 12/04/2018

In mid-2018, ANSTO, together with several State and Federal Government agencies, will undertake Australia’s 10th routine transport of spent nuclear fuel assemblies.

Pamela Naidoo Ameglio 200 x 145
Recent appointment of executive to head Nuclear Operations makes female trio on leadership team: Pamela Naidoo-Ameglio 08/03/2018

When Pamela Naidoo- Ameglio joined ANSTO six weeks ago as Group Executive, Nuclear Operations, she became the third female on the Executive Leadership Team.

Oncosil logo
Multipurpose research reactor providing radioactive phosphorous for implantable medical device to treat pancreatic cancer in global clinical trial 20/02/2018

ANSTO is providing expertise and irradiation services for Australian biomedical company OncoSil Medical

Find more...

Media enquiry form

If you have a media enquiry please call
Phil McCall: +61 438 619 987


Send »

Please provide us with your name, phone number and
email so we can get back to you.

Error: Enquiry was not sent! Check all fields have been populated correctly.
Success: Enquiry was sent successfully.

Publications »